A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).

P. Lorigan; J. M. Larkin; S. Turajlic; P. D. Nathan; G. Stamp; D. Gonzalez de Castro; N. Martin; J. Griffiths; K. Edmonds; S. Sarker; M. G. James; A R.; [Unknown] Hern; G. Coombes; C. Snowdon; J. M. Bliss; M. E. Gore; Richard Marais

A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).

P. Lorigan, J. M. Larkin, S. Turajlic, P. D. Nathan, G. Stamp, D. Gonzalez de Castro, N. Martin, J. Griffiths, K. Edmonds, S. Sarker, M. G. James, A R., [Unknown] Hern, G. Coombes, C. Snowdon, J. M. Bliss, M. E. Gore, Richard Marais

Cancer Research UK Manchester Institute

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - 2011
Event	ASCO - Chicago, USA Duration: 2 Jun 2011 → 6 Jun 2011

Conference

Conference	ASCO
City	Chicago, USA
Period	2/06/11 → 6/06/11

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Lorigan, P., Larkin, J. M., Turajlic, S., Nathan, P. D., Stamp, G., Castro, D. G. D., Martin, N., Griffiths, J., Edmonds, K., Sarker, S., James, M. G., R., A., Hern, U., Coombes, G., Snowdon, C., Bliss, J. M., Gore, M. E., & Marais, R. (2011). A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).. Poster session presented at ASCO, Chicago, USA.

@conference{1a91a64784b747c6b95f6165730e75de,

title = "A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).",

author = "P. Lorigan and Larkin, {J. M.} and S. Turajlic and Nathan, {P. D.} and G. Stamp and Castro, {D. Gonzalez de} and N. Martin and J. Griffiths and K. Edmonds and S. Sarker and James, {M. G.} and A R. and [Unknown] Hern and G. Coombes and C. Snowdon and Bliss, {J. M.} and Gore, {M. E.} and Richard Marais",

year = "2011",

language = "English",

note = "ASCO ; Conference date: 02-06-2011 Through 06-06-2011",

}

Lorigan, P, Larkin, JM, Turajlic, S, Nathan, PD, Stamp, G, Castro, DGD, Martin, N, Griffiths, J, Edmonds, K, Sarker, S, James, MG, R., A, Hern, U, Coombes, G, Snowdon, C, Bliss, JM, Gore, ME & Marais, R 2011, 'A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).', ASCO, Chicago, USA, 2/06/11 - 6/06/11.

TY - CONF

T1 - A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM).

AU - Lorigan, P.

AU - Larkin, J. M.

AU - Turajlic, S.

AU - Nathan, P. D.

AU - Stamp, G.

AU - Castro, D. Gonzalez de

AU - Martin, N.

AU - Griffiths, J.

AU - Edmonds, K.

AU - Sarker, S.

AU - James, M. G.

AU - R., A

AU - Hern, [Unknown]

AU - Coombes, G.

AU - Snowdon, C.

AU - Bliss, J. M.

AU - Gore, M. E.

AU - Marais, Richard

PY - 2011

Y1 - 2011

M3 - Poster

T2 - ASCO

Y2 - 2 June 2011 through 6 June 2011

ER -